Hematology is hot. And these two stocks – a leader in the space and a much more speculative up-and-coming drugmaker – could be the most intriguing plays in this multibillion-dollar industry. CLICK HERE.
By using this site, you agree to the storage of cookies on your device for enhanced navigation, site analysis, and GATS's marketing. Data sharing with social media platforms might occur based on the privacy choices you make on those platforms. For specifics, see our Privacy Policy.OkayPrivacy policy